Silver Trend Alerts: Update 4th May 2011

By Editorial Team -
  • Price closed below 20 Daily Simple/Exponential Moving Average
  • Realized Profit:  USD 43.00 - USD 30.3/oz = USD 12.7/oz (142%)
  • Duration:  3 months
  • Return On Investment:  168 % per annum
  • Leverage: 10 X
  • Return On Investment:  1680 % per annum
 Please refer to previous posts:
http://onedaymba.blogspot.com/2011/03/online-gold-and-silver-trend-alerts.html
http://onedaymba.blogspot.com/2011/02/online-gold-and-silver-trend-daily.html
http://onedaymba.blogspot.com/search?updated-min=2010-01-01T00%3A00%3A00-08%3A00&updated-max=2011-01-01T00%3A00%3A00-08%3A00&max-results=3

Please feel free to share your experience under 'post a comment' for the benefit of other readers. Thank you!

Related terms: Forex, Gold, Silver, trend, alerts, signals, trading, investment, gold price, spot gold, price of gold, gold spot, forex trading, forex charts, forex factory, forex market, CFD, trader

Comments

Post a Comment

Pages

Popular posts from this blog

Top 10 Food Companies by Revenue (2025)

By -
Image
Based on the most recent 2025 revenue data as of November 2025 (using trailing twelve months or fiscal 2024 figures where full calendar 2025 data is not yet available due to ongoing reporting), here are the top 10 food companies ranked by revenue. This update incorporates latest quarterly reports, TTM figures, and industry rankings from sources like Food Engineering's 2025 Top 100 Food and Beverage Companies, which notes PepsiCo surpassing Nestlé for the top spot based on reported sales. Top 10 Food Companies by Revenue (2025) This ranking reflects the largest companies primarily by annual revenue, emphasizing food production, processing, distribution, and retail sectors globally ( 1 ,  4 ). 1. Nestlé (Switzerland) Annual Revenue: USD  $113 billion ( nestle.com ) Key Brands: Nescafe, KitKat, Maggi, Purina, Waters Headquarters: Vevey, Switzerland Global Footprint: 188 countries Strategic Significance: World’s largest food manufacturer Notes:  World's largest food ...
Read more

Top XRP ETFs to Watch in 2025: Dominating Holdings, Low Fees, and Performance Insights (November 2025 Update)

By -
Image
On November 13, 2025,  Canary Capital's Canary XRP ETF (ticker: XRPC) became the first pure-play spot XRP ETF to trade on a major U.S. exchange (Nasdaq). Its debut was explosive: $58 million in day-one trading volume — the highest of any ETF launched in 2025 — and early inflows topping $245 million, edging out even the strongest Solana ETF debut. The floodgates opened immediately. Major issuers like Franklin Templeton, Bitwise, Grayscale, 21Shares, and others rushed final amendments, leveraging streamlined SEC processes to bring competing spot products live within days. As of November 19, 2025, the U.S. now has multiple spot XRP ETFs trading or imminently launching, marking XRP's full arrival into mainstream institutional finance. This rapid rollout validates years of anticipation: resolved regulatory hurdles, proven real-world utility on the XRP Ledger, and surging demand for diversified crypto exposure beyond Bitcoin and Ethereum. Analysts now project $5–10 billion+ in cumul...
Read more

Top 10 Pharmaceutical Companies by Revenue and Market Cap in 2025 (November Edition)

By -
Image
The pharmaceutical industry continues to show robust performance in Q3 2025, with key players reporting strong sales driven by oncology, immunology, and metabolic drugs. Eli Lilly maintains its lead in market capitalization, fueled by high demand for its GLP-1 treatments Mounjaro and Zepbound, with projected full-year revenue growth of around 32%. Johnson & Johnson reported Q3 sales of $24.0 billion, up 6.8%, and raised its 2025 sales outlook. Roche achieved 7% sales growth in the first nine months to CHF 45.9 billion ($52.8 billion), raising its full-year guidance to mid-single-digit growth. Other top companies like AstraZeneca, Novartis, and Vertex reported double-digit growth in key segments. Challenges persist, including patent expirations and biosimilar competition, but new approvals and acquisitions signal continued innovation. This edition updates data with Q3 2025 figures where available. Credit:  fiercepharma.co...
Read more

Top 10 Gold and Silver ETF Picks for November 2025: Best Investments for Hedging Amid Inflation, Tariff Adjustments, and Fed Easing

By -
Image
Introduction As November 2025 unfolds, the stock market navigates a complex and evolving landscape shaped by President Trump's adjusted tariff policies, which have moderated slightly but still contribute to persistent inflation around 3.4% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.875% so far this year—have ignited a powerful market melt-up, with the S&P 500 rallying 39% over the past six months on strong corporate earnings and AI optimism.  Gold prices have surged past $4,150 an ounce as a hedge and inflation buffer, while cryptocurrencies continue to hit new highs and maintain their upward trajectory. However, warnings of an AI bubble abound and linger, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy or if policies change.  Silver prices have risen above $55 per ounce and reached an all time high last month, fueled by industrial demand in ...
Read more

Tech and Innovation ETFs in 2025: Top Picks, Strategies, and Risks

By -
Image
As we enter the latter half of 2025, the technology sector continues to dominate global markets, driven by breakthroughs in artificial intelligence (AI), semiconductors, robotics, and cloud computing. With the S&P 500's tech component accounting for over 34% of the index and the Nasdaq-100 even more heavily weighted toward innovation-driven companies, tech and innovation ETFs offer investors a streamlined way to capitalize on these trends. These exchange-traded funds (ETFs) provide diversified exposure to high-growth areas without the need to pick individual stocks, reducing some of the inherent risks while maintaining potential for substantial returns. Update:  Top 10 Stocks and ETFs Poised to Outperform in November 2025 This guide explores the current market landscape, key selection criteria for ETFs, top picks for 2025, portfolio-building strategies, associated risks, and forward-looking forecasts. Whether you're a beginner investor or a seasoned portfolio manager, this ...
Read more

5 Best GPUs for AI Video Generation 2025

By -
Image
As AI video generation tools like Stable Video Diffusion, Runway ML, and emerging models from OpenAI continue to evolve, having the right GPU is crucial for creators, developers, and enthusiasts. In 2025, AI video workflows demand high VRAM for handling large models, efficient tensor cores for acceleration, and robust support for frameworks like PyTorch and TensorFlow. NVIDIA remains the leader due to its CUDA ecosystem, but AMD offers competitive alternatives with improving ROCm support. This guide ranks the best GPUs based on performance, VRAM, power efficiency, and value for AI video tasks such as text-to-video, video upscaling, and style transfer. Key Factors to Consider When Choosing a GPU for AI Video Generation Before diving into recommendations, here's what matters most in 2025: VRAM Capacity : Aim for at least 24GB to run high-resolution models without batching or offloading. Architecture : NVIDIA's Blackwell (RTX 50-series) offers multi-frame generation (MFG) for fast...
Read more

Top 10 Fastest-Growing Food Companies of 2025: Beyond the Revenue Giants – Spotlight on GLP-1 Snacks

By -
Image
The top 10 fastest-growing food companies of 2025 include innovative brands like Poppi, Liquid Death, and Chomps, all known for their focus on health, sustainability, and product innovation. Other notable companies reshaping consumer choices in the industry are Olipop, Melinda's, and Tru Fru. These companies are distinguished by their rapid revenue growth and influence on evolving food and beverage trends that prioritize wellness and environmental responsibility. While giants like Nestlé and PepsiCo hold steady with billions in sales, the industry's innovators are surging, especially in the GLP-1 snack space. GLP-1 receptor agonists (think Ozempic, Wegovy) have reshaped snacking: users crave high-protein, portion-controlled, gut-friendly options to combat side effects like nausea and muscle loss, fueling a $53 billion global market boom.  Trends include protein-packed bars, fiber-rich sodas, and small-portion treats, with 77.6% of GLP-1 shoppers tweaking habits b...
Read more

Top 10 Stocks and ETFs Poised to Outperform in November 2025

By -
Image
As November 2025 unfolds, the stock market navigates a complex and evolving landscape shaped by President Trump's adjusted tariff policies, which have moderated slightly but still contribute to persistent inflation around 3.4% and economic uncertainty. Despite these headwinds, the Federal Reserve's ongoing rate cuts—totaling 0.875% so far this year—have ignited a powerful market melt-up, with the S&P 500 rallying 39% over the past six months on strong corporate earnings and AI optimism. Gold prices have surged past $4,150 an ounce as a hedge and inflation buffer, while cryptocurrencies continue to hit new highs and maintain their upward trajectory. However, warnings of an AI bubble abound and linger, with elevated valuations in tech giants signaling potential risks that may not materialize until the Fed tightens policy or if policies change. Drawing from analyses by Zacks, Forbes, ValueSense, US News, Morningstar, Bankrate, and Motley Fool, this list highlights 10 high-conv...
Read more

Top 10 Pharma Companies by Market Cap in 2025

By -
Image
Here are the top 10 pharmaceutical companies by market cap. The pharmaceutical industry remains robust amid evolving market dynamics, driven by innovation, strategic expansions, and shifting healthcare policies. This 2025 update integrates the first half's (H1) financial results to provide readers with a clear snapshot of leading companies’ performance and trajectory. In contrast, most of the other top 10 pharmaceutical companies are expected to see more moderate revenue growth, generally in the range of 6% to 9% by the end of 2025. This reflects steady but less dramatic expansion compared to Eli Lilly’s exceptional performance ( 4 ). Source: CompaniesMarketCap.com Lilly—boosted by sales of its diabetes and obesity drugs Moujaro and Zepbound— projects  its sales to fall between $58 billion and $61 billion. Meanwhile, Novo—which also has been powered by sales...
Read more

Top 10 ETF Picks for November 2025: Best Investments for Growth Amid AI Surge, Tariff Adjustments, and Ongoing Fed Easing

By -
Image
Introduction As November 2025 progresses, the stock market contends with an evolving backdrop marked by President Trump's adjusted tariff policies, which have moderated but sustain inflationary pressures near 3.3%. The Federal Reserve's total 1.00% rate cuts this year have ignited a powerful rally, driving the S&P 500 up 42% over the past six months, fueled by stellar earnings and AI progress. Gold has surpassed $4,300 per ounce as an inflation buffer, while cryptocurrencies maintain their upward trajectory. However, AI bubble worries linger, with lofty tech valuations susceptible to shifts if policies change. Aggregated from insights by Zacks, Forbes, Morningstar, Bankrate, and Motley Fool, this list spotlights 10 premier ETFs emphasizing AI innovation, sturdy sectors, and diversified strategies to traverse economic divides. Top 10 ETFs Selections highlight YTD performance, AUM for dependability, and anticipated growth in AI, tech, healthcare, and broad markets. Data sourc...
Read more